Abstract:BACKGROUND:Cutaneous T cell lymphoma (CTCL) comprises a heterogeneous group of skin-homing T cell tumors. The small guanosine triphosphate effector p21-activated kinase 1 (PAK1) plays an important role in many fundamental cellular functions, including cell motility, proliferation, and apoptosis. The expression of PAK1 is up-regulated in several types of human cancers. However, little is known about the role of PAK1 in the pathogenesis of CTCL.OBJECTIVE:The aim of this study was to evaluate the expression pattern and underlying mechanism of PAK1 in CTCL.METHODS:Quantitative real-time polymerase chain reaction(qRT-PCR) was used to detect PAK1 mRNA expression in the peripheral blood mononuclear cells (PBMCs) of patients with CTCL. The expression of PAK1 protein in CTCL tumor tissues was determined by immunohistochemistry. CTCL cell lines were treated with a small molecule inhibitor of PAK1, p21-activated kinase inhibitor III (IPA3), at concentrations of 2, 3.5 and 5 μM for 24 h. Hut 78 and HH CTCL cells were transfected with lentiviral-based PAK1 gene knockdown vectors. We determined the effects of PAK1 knockdown on cell proliferation and apoptosis in CTCL cells by MTS assay and flow cytometry. Animal experiments were performed to investigate the effects of PAK1 knockdown on the growth of tumors in vivo. Transcriptomic sequencing was performed to detect the direct downstream targets of PAK1 silencing. Reverse transcription polymerase chain reaction and western blot analysis were applied to verify the results of the transcriptomic analysis.RESULTS:We detected PAK1 overexpression in PBMCs and skin lesions from patients with CTCL compared with benign inflammatory dermatoses (BID). Knockdown of PAK1 inhibited cell proliferation and promoted spontaneous apoptosis. In addition, the inhibitory effect of IPA3 was validated in the CTCL cell lines. Additionally, mice injected with PAK1-silenced cells presented with a decreased rate of tumor growth compared with the control groups. Moreover, the mRNA and protein expression of PUMA (BBC3) and p21 (CDKN1A) were increased in PAK1-silenced Hut 78 and HH cells.CONCLUSIONS:Our data indicated that PAK1 is upregulated in CTCL. PAK1 silencing induced apoptosis and inhibited cell growth by stimulating the expression of PUMA and p21. Thus, PAK1 may be a potential tumor marker and therapeutic target of CTCL.

P21-activated Kinase 1 Promotes Colorectal Cancer Survival by Up-Regulation of Hypoxia-Inducible Factor-1Α

PAK1-dependent MAPK Pathway Activation is Required for Colorectal Cancer Cell Proliferation

Depletion of P21-Activated Kinase 1 Up-Regulates the Immune System of APC∆14/+ Mice and Inhibits Intestinal Tumorigenesis

Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1.

P21-Activated Kinase 5 is Overexpressed During Colorectal Cancer Progression and Regulates Colorectal Carcinoma Cell Adhesion and Migration

P21-Activated Kinase 5 Inhibits Camptothecin-Induced Apoptosis in Colorectal Carcinoma Cells

P21-activated Kinase 1 and Breast Cancer

PAK5 Facilitates the Proliferation, Invasion and Migration in Colorectal Cancer Cells

P21-activated Protein Kinase 1 Induces Colorectal Cancer Metastasis Involving ERK Activation and Phosphorylation of FAK at Ser-910.

p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation

High-level Expression of P21-Cdc/Rac-activated Kinase 7 is Closely Related to Metastatic Potential and Poor Prognosis of Colon Carcinoma.

Effect of P21-Activated Kinase-1 on the Invasiveness of Colorectal Carcinoma Cells in Vitro

A Rac1/PAK1 cascade controls β-catenin activation in colon cancer cells

Reduced Expression of P21-Activated Protein Kinase 1 Correlates with Poor Histological Differentiation in Pancreatic Cancer

PAK1 Promotes Proliferation, Migration and Invasion of Hepatocellular Carcinoma by Facilitating EMT Via Directly Up-Regulating Snail.

PBK Enhances Cellular Proliferation With Histone H3 Phosphorylation and Suppresses Migration and Invasion With CDH1 Stabilization in Colorectal Cancer

CDK15 promotes colorectal cancer progression via phosphorylating PAK4 and regulating β-catenin/ MEK-ERK signaling pathway

PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo

P21-Activated Kinase 1 Determines Stem-Like Phenotype and Sunitinib Resistance Via NF-κB/IL-6 Activation in Renal Cell Carcinoma

PAKs in Human Cancer Progression: From Inception to Cancer Therapeutic to Future Oncobiology.

PAK1 Overexpression Promotes Cell Proliferation in Cutaneous T Cell Lymphoma Via Suppression of PUMA and P21